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INTRODUCTION
Despite more than 50 years of research, the availability of a diverse
range of antipsychotics from different chemical classes, and the
development of evidence-based treatment guidelines, a significant
proportion of patients with schizophrenia suffer from treatment
resistance (1). As a result, the application of non-invasive brain
stimulation techniques as add-on treatment options for schizo-
phrenia has gained much attention in the last decade. For instance,
repetitive transcranial magnetic stimulation (rTMS) has been used
for the treatment of persistent auditory hallucinations and nega-
tive symptoms. However, as discussed elsewhere this results have
been inconsistent (2) and meta-analyses have reported moderate
to low effect sizes for these interventions (3). More recently, tran-
scranial direct current stimulation (tDCS) has been introduced to
treatment studies in patients with schizophrenia (4–10). Com-
pared to rTMS, tDCS offers the possibility of non-focal brain
stimulation with a current flow between two electrodes (anode
and cathode) and allows the active stimulation of two locations
on the scalp (11). tDCS modulates spontaneous neuronal activity
via a subthreshold tonic depolarization (anodal tDCS) or hyper-
polarization (cathodal tDCS) of neuronal membranes (11–14).
Both animal and human studies have indicated that these polarity
changes are related to the molecular processes underlying long-
term potentiation (LTP) and long-term depression (LTD) (15–20).
The classical electrode montage placed one electrode over the
primary motor cortex (M1) and the other electrode over the con-
tralateral orbitofrontal cortex (OFC) (11, 15). This M1-OFC setup
has been established as the gold standard for motor-cortical stim-
ulation, with alternative setups (e.g., left M1 – right M1) shown
to be ineffective in early studies for short stimulation durations
(11, 15). However, recent publications have shown that bilateral
application of tDCS on the primary motor cortices can in fact be
effective in modulating cortical excitability on both hemispheres
in healthy humans (21). Imaging studies indicate that unilateral
and bilateral tDCS have fundamental differences in their physi-
ological mode of action. Bilateral tDCS applied to M1 in both
hemispheres has been found to cause a decrease in interhemi-
spheric functional connectivity during the stimulation session,
but an increase in intracortical functional connectivity beyond the
stimulation period (22). In contrast, unilateral stimulation results
in the same online-effects, but induces no changes that persist fol-
lowing the termination of stimulation (22). Furthermore, as with
other transcranial brain stimulation techniques, tDCS only mod-
ulates cortical excitability at the stimulated site, but also impacts
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interconnected cortical areas (e.g., via transcallosal fibers) (23, 24).
The possibility to modulate the excitability balance between two
hemispheres, or more specifically between two cortical areas, for
treatment purposes has gained considerable attention. Indeed, it
has been specifically investigated in the context of neuropsychi-
atric disorders such as stroke (bilateral stimulation of both M1)
(25, 26), depression (bilateral stimulation of both DLPFCs) (27,
28), and schizophrenia (left DLPFC, left temporo-parietal cortex)
(5). In schizophrenia, treatment studies or case reports [e.g., Ref.
(5, 6, 9)] have mainly used a unilateral tDCS montage, although
some case reports using a bilateral tDCS montage (e.g., left tempo-
parietal cortex, right supraorbital area, or left and right prefrontal
cortex) have also been reported (4, 7).
Previous physiological tDCS studies showed that classical uni-
lateral cathodal tDCS failed to induce LTD-like plasticity on
both the stimulated and non-stimulated hemispheres, indicating
a deficient response capacity of the motor cortex and impair-
ments in functional connectivity in patients with schizophrenia
(29, 30). Furthermore, LTP-like responses following anodal tDCS
were found to be abolished in chronically ill individuals but not
in recent-onset patients with schizophrenia, and these deficits
were associated with altered inhibitory networks (31). Studies
using other stimulation techniques are compatible with the tDCS
findings, with patients with schizophrenia displaying reduced
motor-cortical plasticity following paired-associative stimulation
(32) and inhibitory 1 Hz-rTMS (33), as well as diminished
use-dependent plasticity (34).
Given the observed impairment in cortical plasticity and the
theories of an association between impaired plasticity and dyscon-
nectivity in patients with schizophrenia (35, 36), bilateral stimu-
lation may offer an interesting opportunity to impact positively
on these disturbed networks. However, little is known about
the physiological underpinnings of bilateral tDCS in patients
with schizophrenia. Therefore, the aim of the present proof-
of-concept study was to determine the difference in the effi-
cacy of bilateral and unilateral tDCS applied to the primary
motor cortices in patients with schizophrenia compared to healthy
controls.
MATERIALS AND METHODS
SUBJECTS
Ten patients with paranoid schizophrenia and 10 age- and sex-
matched healthy subjects participated in this study after giving
informed consent. As a recent publication reported that differ-
ences in handedness modulate the effects of tDCS and hemispheric
connectivity (37), the left-handed subjects (one in each group)
were excluded from analyses, leading to a total sample size of
18. Subjects with a history of dermatological diseases, dementia,
neurological illnesses, severe brain injuries, or brain tumors were
excluded from the study. The local ethics committee approved the
protocol in accordance with the Declaration of Helsinki.
The clinical consensus diagnosis of schizophrenia was made
independently by two psychiatrists of the study group (Alkomiet
Hasan and Thomas Wobrock), based on the ICD-10 criteria. All
subjects underwent a standardized test of hand preference (38)
and patients also had their psychopathology (Positive and Nega-
tive Syndrome Scale, PANSS) (39), disease severity (Clinical Global
Impression, CGI) (40), and psychosocial functioning (Global
Assessment of Functioning, GAF) (41) assessed.
All patients with schizophrenia were receiving treatment with
second-generation antipsychotics [seven in monotherapy, two
combination treatment (one first-generation antipsychotic)]. No
other concomitant CNS-active medications, other than biperiden
were allowed. Chlorpromazine (CPZ) equivalents were calculated
for each patient (42).
tDCS PROCEDURE
Transcranial direct current stimulation was applied, using a com-
mercially available DC stimulator (Eldith-Electro-Diagnostic and
Therapeutic Systems GmbH, Ilmenau, Germany), through saline
soaked surface sponge electrodes (35 cm2). For unilateral tDCS,
the cathode was placed over left M1 and the anode was located
contralaterally above the right orbit. Bilateral tDCS was performed
by placing the cathode over left M1 and the anode over right M1.
A continuous current flow of tDCS, with an intensity of 1 mA, was
applied for 9 min in the unilateral and for 13 min in the bilateral
configuration. For unilateral tDCS, the application of 9–13 min
was shown to produce long-lasting reduction of M1 excitability
(up to 1 h) (14, 16). The decision for 9 min unilateral tDCS was
made to allow the comparison with other tDCS studies in schiz-
ophrenia [e.g., Ref. (29, 30)] and the decision for 13 min bilateral
tDCS was made to be in the time frame for long-lasting anodal
after-effects (14).
TMS PROCEDURE AND MONITORING OF EXCITABILITY CHANGES
To determine M1 excitability with single-pulse motor-evoked
potential (MEP) measurements before and after tDCS, a previ-
ously described setup was used and adopted for the bihemispheric
measurements (29, 30). Subjects were seated in a comfortable
reclining chair with a passive arm support. Electromyographic
(EMG) recordings from the right and left first-dorsal interosseous
(FDI) muscles were made with surface electrodes. Raw signals were
amplified, bandpass-filtered (2 Hz–10 kHz), and digitized using a
commercially available amplifier. Each EMG recording was manu-
ally analyzed offline. TMS was performed with a biphasic MagPro
X 100 magnetic stimulator (Medtronic Co., Copenhagen, Den-
mark) and TMS was applied to the hand area of the left and
right motor cortices with a standard figure-of-eight magnetic coil.
In accordance with other studies, the coil was held tangentially
to head with the handle pointing backward and at an angle of
45° lateral to the midline. This setup induced a posterior-anterior
directed current in the cortex.
The optimal coil position was defined as the stimulation site
that produced the largest MEP at moderately suprathreshold stim-
ulation intensities in the resting FDI muscles. The optimal posi-
tions were marked to ensure that the coil was held in the correct
position and orientation throughout all experiments.
Single-pulse TMS before and after each stimulation procedure
was performed at an intensity that evoked MEPs of about 1 mV
(S1 mV, peak to peak, 0.7–1.3 mV) over left and right M1. We
measured 30 MEPs at baseline, and 1 and 15 min after stimula-
tion. Baseline cortical excitability was further determined only
before stimulation by measuring the resting-motor threshold,
short-latency intracortical inhibition (SICI), and cortical silent
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period (CSP). SICI was recorded with a standardized paired-pulse
protocol (conditioning stimulus: 80% RMT, test stimulus: S1 mV,
interstimulus interval (ISI): 3 ms) (43). We performed 10 trials
with 3 ms ISI and the 30 MEPs were used as test pulse compari-
son. The effect of the conditioning stimulus on MEP amplitude
of the test stimulus was determined by calculating the ratio of the
average amplitude of the conditioned paired-pulse MEP to the
average amplitude of the unconditioned single-pulse test MEP.
Finally, CSP was measured in the tonically active FDIs (25–30%
of maximal contraction) by stimulating the contralateral motor
cortex with an intensity of 120% RMT. Ten trials were performed
and the mean CSP duration calculated.
EXPERIMENTAL DESIGN
To compare unilateral and bilateral tDCS in both study groups,
all 18 subjects were tested on two different days (time-interval
3–7 days), resulting in 36 experimental sessions. The study was
designed as a balanced, complete-crossover study in a repeated
measurement design (Figure 1).
STATISTICAL ANALYSES
SPSS 20 for Windows was used for all analyses, and the level
of significance was defined as α= 0.05. For gender, Chi square
tests were computed to test for group differences. Independent-
samples t -tests were used to compare mean ages and baseline
excitability (S1 mV, RMT, SICI, CSP) between the groups. A
repeated-measures ANOVA (RM-ANOVA) was calculated with
the between-subject variable “group” (healthy subjects vs. patients
with schizophrenia) and the within-subject variables “timecourse”
(baseline, post-stimulation 1 and 15 min), “hemispheres” (left,
right), and “stimulation” (bilateral, unilateral). Since there was
only a trend-level interaction in the overall ANOVA for “stimu-
lation× timecourse× group” when we examined the data points
post-tDCS, we averaged all time-points to give a mean post-tDCS
excitability measure (“time”) for all consecutive statistical analy-
ses. To determine more specifically whether the MEP amplitudes
before and after tDCS differed within- and between-groups, hemi-
spheres, and stimulation types, Student’s t -tests (independent-
samples for the intergroup comparisons, and paired-samples for
the intragroup pre versus post comparisons, two-tailed, P < 0.05)
were performed where appropriate (significant interactions in the
ANOVA). T -tests were not adjusted for multiple comparisons
in cases of significant interaction in the RM-ANOVAs. Spheric-
ity was tested using Mauchly’s test and, if necessary (Mauchly’s
test<0.05), the Greenhouse–Geisser correction was applied. Pear-
son correlations between dependent variables and CPZ equiva-
lents were performed in the patient group. Data are presented as
mean± SD unless otherwise indicated.
RESULTS
SOCIODEMOGRAPHIC VARIABLES AND CLINICAL RATINGS
Analyses revealed no group differences for age (p= 0.455) and gen-
der distribution (p= 1.000). Patients with schizophrenia were all
stable (at least 1 week with the same medication; medications sta-
ble for both measures) and showed moderate positive and negative
symptoms and moderate degree of illness and impairment. Demo-
graphic and clinical characteristics as well as CPZ equivalents of
the study groups are presented in Table 1.
BASELINE EXCITABILITY FOR BOTH HEMISPHERES
Independent t -tests between both groups comparing the left and
right hemispheres revealed no significant differences for S1 mV,
RMT, MEP amplitudes, SICI, or CSP (see Table 2). However,
patients with schizophrenia had a numeric reduction in SICI on
both hemispheres and a numeric prolongation in CSP of the
left hemisphere. Although this can be explained by the small
FIGURE 1 | Experimental course and study design. All subjects participated in two experimental sessions (unilateral DCS, bilateral tDCS). Corticospinal
excitability was assessed before and after tDCS stimulation on both hemispheres.
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Table 1 | Demographic and clinical characteristics of the subjects.
Variable n Healthy
controls
Schizophrenia
patients
Statistics
Subjects (n) 18 9 9
Age (years) 18 28.9±12.5 34.0±10.2 p=0.455a
Gender (f/m) 18 3/6 3/6 p=1.000b
PANSS score
Total 9 – 58.1±19.9
Positive 9 – 12.1±6.8
Negative 9 – 16.6±4.2
General 9 – 29.4±11.1
GAF 9 – 57.6±15.1
CGI 9 – 4.1±1.7
CPZ (daily) 9 – 453.7±284.5
DUP (years) 9 – 6.4±6.1
n=Number of subjects; f= female; m=male; r= right; l= left; PANSS=Positive
and Negative Syndrome Scale; GAF= global assessment of function-
ing; CGI= clinical global impression; CPZ= chlorpromazine equivalent dose;
DUP= duration of psychosis; a independent-samples t-test; bChi square test. Data
are presented as mean±SD.
Table 2 |TMS baseline parameters.
Variable n Healthy
controls
Schizophrenia
patients
Statistics
LEFT HEMISPHERE
RMT (%) 18 46.8±7.6 46.1±18.8 p=0.922
S1 mV (%) 18 54.6±8.2 57.3±23.4 p=0.742
CSP (ms) 18 138.0±23.9 112.8±42.1 p=0.137
SICI 3 ms (%) 18 23.7±26.4 50.7±26.4 p=0.261
RIGHT HEMISPHERE
RMT (%) 18 37.7±16.1 42.3±24.9 p=0.791
S1 mV (%) 18 46.8±18.8 50.7±30.3 p=0.748
CSP (ms) 18 126.0±24.0 126.1±38.5 p=0.994
SICI 3 ms (%] 18 40.1±57.0 55.1±87.4 p=0.681
Statistics= independent t-tests; RMT= resting-motor threshold;
S1 mV= intensity to evoke a MEP of ∼1 mV; CSP= contralateral silent
period; SICI= short-latency intracortical inhibition. Data are presented as
mean±SD.
sample size, it is in line with many previous studies [for review
see Ref. (44)].
EFFECTS OF PLASTICITY INDUCTION
Since there was only a trend-level interaction “stimu-
lation× timecourse× group” in the first RM-ANOVA, we
pooled the post-tDCS MEP measures for a compound
mean analysis (Figures 2A,B). The results of this ANOVA
are presented below (Table 3). The RM-ANOVA with the
main factors “stimulation,” “hemisphere,” “time,” and “group”
revealed significant effects for the “stimulation× time× group”
interaction (p= 0.027), trend-level interactions for “stimu-
lation× hemisphere× group” (p= 0.083), “stimulation× time”
(p= 0.090), and “hemisphere× time” (p= 0.081), but no further
interactions or main effects (all p≥ 0.119). Based on the “stim-
ulation× time× group” interaction, further analyses were con-
ducted. However, because no significant interactions involving
the factor “hemisphere” were detected, no analyses between
hemispheres were performed.
In the healthy control group, paired-sample t-tests showed an
increase in MEP amplitude following bilateral tDCS on the right
(anodal) [t (8)= 2.710, p= 0.027], but not on the left (cathodal),
hemisphere [t (8)= 0.344, p= 0.740]. After unilateral tDCS, MEPs
were reduced on the left hemisphere (cathodal) [t (8)= 2.683,
p= 0.028], but not on the non-stimulated right hemisphere
[t (8)= 0.136, p= 0.895]. Contrary to these findings, patients with
schizophrenia showed no modulation of MEP amplitude follow-
ing unilateral or bilateral tDCS on the left [all t (8) < 0.132, all
p> 0.899] and right hemispheres [all t (8) < 1.235, all p> 0.252].
For bilateral tDCS, independent-samples t-tests showed no
MEP baseline differences between healthy controls and patients
with schizophrenia on the left [t (16)= 0.364, p= 0.721] or right
[t (16)= 1.623, p= 0.124] hemispheres. After stimulation, no dif-
ferences between groups could be detected on the left hemisphere
(cathodal) [t (16)= 0.382, p= 0.708]. However, on the right hemi-
sphere (anodal), healthy controls showed significantly higher MEP
values after stimulation compared to patients with schizophrenia
[t (16)= 2.359, p= 0.031].
For unilateral tDCS, independent-samples t-tests again showed
no MEP baseline differences between healthy controls and patients
with schizophrenia on the left [t (16)= 0.722, p= 0.481] or right
[t (16)= 0.469, p= 0.645] hemispheres. Additionally, after tDCS
no differences across groups could be detected on the left
[t (16)= 0.501, p= 0.623] and right hemisphere [t (16)= 0.531,
p= 0.602].
INFLUENCE OF CLINICAL SYMPTOMS AND ANTIPSYCHOTIC
MEDICATION
Pearson correlations between dependent variables and CPZs
revealed a positive correlation between CPZ equivalents and MEP
amplitudes at baseline (unilateral, right hemisphere) (p= 0.047).
The detected correlations were, however, non-significant after cor-
rection for multiple analyses, and thus have to be interpreted with
caution.
DISCUSSION
The results of this first proof-of-concept study comparing clas-
sic unilateral cathodal tDCS with simultaneous bilateral tDCS
indicate that cortical plasticity is impaired in patients with schizo-
phrenia following both stimulation protocols. Unilateral cathodal
tDCS reduced MEP amplitudes on the stimulated hemisphere in
healthy controls, but not in patients with schizophrenia. No effect
on the non-stimulated hemisphere following left M1 cathodal
tDCS could be observed in either group. The recently intro-
duced bilateral tDCS paradigm (here: cathodal tDCS over the
left M1 and anodal tDCS over the right M1) facilitated MEPs
on the right hemisphere but had no effect on the left hemisphere
in healthy controls. However, in patients with schizophrenia, no
excitability modulation following tDCS could be observed on
either hemisphere. The pattern of our results indicates global
deficits of cortical plasticity in the schizophrenia brain and offers
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FIGURE 2 | Absolute change of MEP size pre- and post-tDCS.
(A) Healthy controls display an increase of MEPs after bilateral tDCS on
the right (anodal), but not on the left hemisphere (cathodal). Following
unilateral tDCS, healthy controls show reduced MEPs on the
stimulated left, but not on the non-stimulated right hemisphere.
(B) Patients with schizophrenia show abolished plasticity following both
stimulation paradigms on both hemispheres. For details please see
Section “Results.”
new insights into the interplay between plasticity and connectivity
in this population.
BILATERAL tDCS FOR BIHEMISPHERIC EXCITABILITY MODULATION IN
HEALTHY CONTROLS
The initial paper by Nitsche and Paulus (15) tested different elec-
trode positions and found the maximum effect for anodal and
cathodal stimulation placing the motor cortex stimulation elec-
trode over the left M1 and the return electrode on the contralateral
supraorbital side. However, they did not observe any excitability-
modulating effects using bilateral motor cortex electrode montage
during a short DC stimulation for 4 s, which does not induce
after-effects (15). A recently published study was able to show an
excitability-modulating effect of bilateral tDCS applied to both
motor cortices (21). Mordillo-Mateos et al. (21) investigated sys-
tematically bilateral M1 tDCS and showed that bilateral tDCS
enhanced cortical excitability on the anodal-stimulated side and
decreased cortical excitability at the cathodal-stimulated site, irre-
spective of whether anode and cathode were placed over left or
right M1. The bilateral setup in our study led to an excitability-
enhancing effect of anodal tDCS applied to the right M1, but we
were not able to show an excitability-diminishing effect following
cathodal tDCS applied to left M1. The differences between both
studies could possibly be explained by the stimulation duration
(5 min compared to 13 min bilateral tDCS in our study) and the
stimulation intensity (2 mA compared to 1 mA in our study). It is
well-established that modulation of these parameters impact on
the after-effects that follow unilateral tDCS (11, 15, 45) and it is
very likely that related effects occur using the bilateral electrode
montage. Another study reported a MEP increase following both
unilateral and bilateral anodal tDCS applied with 1 mA for 13 min
to the left M1, with no differences between protocols. However,
www.frontiersin.org October 2013 | Volume 4 | Article 121 | 5
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Table 3 | Results of the RM-ANOVAs for MEP values.
Hypothesis
df, error df
F value pValue
MEP-amplitudes (baseline, mean post)
Time 1, 16 1.327 0.266
Hemisphere 1, 16 2.157 0.161
Stimulation 1, 16 0.001 0.980
Time×group 1, 16 0.195 0.266
Hemisphere×group 1, 16 0.762 0.396
Stimulation×group 1, 16 2.710 0.119
Time×hemisphere 1, 16 3.475 0.081#
Time× stimulation 1, 16 3.254 0.090#
Hemisphere× stimulation 1, 16 0.464 0.506
Time×hemisphere×group 1, 16 1.710 0.209
Time× stimulation×group 1, 16 5.922 0.027*
Hemisphere× stimulation×group 1, 16 3.422 0.083#
Time×hemisphere× stimulation 1, 16 0.261 0.616
Time×hemisphere× stimulation×group 1, 16 1.102 0.309
The analyses show a significant “time× stimulation×group” interaction
for MEP amplitudes and trend-level findings for “time×hemisphere” and
“time× stimulation.” In cases of lacking interactions, no further t-tests were
conducted. *p≤0.05; #p≤0.09.
right M1 excitability was not reported (46). Our results are in
line with recent publications indicating a modulatory effect on
M1 excitability following bilateral tDCS in healthy subjects, with
methodological differences across studies accounting for diverse
results. Further systematic evaluations are needed to clarify the
biological impact of bilateral tDCS.
IMPAIRED CORTICAL PLASTICITY IN PATIENT WITH SCHIZOPHRENIA
FOLLOWING BOTH STIMULATION PARADIGMS
Cathodal unilateral tDCS failed to reduce MEP amplitudes on
the stimulated hemisphere in patients with schizophrenia. This
has already been shown by our group in large samples (29, 30) and
this present result confirms these findings. However, in the present
study we were not able to show differences in MEP modulation
between healthy controls and patients with schizophrenia on the
non-stimulated hemisphere. In both groups, no effect on the non-
stimulated right M1 could be observed following cathodal tDCS
applied to left M1. This is in contrast to a study published by our
group (30), but in line with an earlier study conducted in healthy
subjects (47). Both our present study and that published by Lang et
al. had rather small sample sizes (N = 9, respectively N = 8) and,
therefore, these studies might not have enough statistical power to
detect such subtle modulations which are subject to large between-
subject variability. Bilateral tDCS enhanced MEPs on the anodal
site (right M1), but had no effect on the cathodal site (left M1) in
healthy subjects. However, in patients with schizophrenia, bilateral
tDCS on neither the left nor the right hemisphere was able to mod-
ulate cortical excitability, indicating deficient cortical plasticity, at
least at the anodal site. To the best of our knowledge, only one
study has investigated the physiological effects of anodal tDCS on
M1 excitability in patients with schizophrenia so far. In this study,
anodal tDCS applied to left M1 failed to increase MEP amplitudes
in chronically ill patients, but led to a sufficient MEP-facilitation
in early-disease-stage patients and healthy controls (31).
Impaired plasticity is one of the best established neurobio-
logical theories of schizophrenia. The term plasticity refers to
the brain’s capacity to respond to external stimuli and it is
associated with modulations of synaptic activity, micro- and
macro-connectivity, and neural integrity (48–50). The molecu-
lar processes underlying plasticity are LTP and LTD, and their
functioning is critically dependent on the activity of N -methyl-d-
aspartate-receptors (NMDAR) (51). A dysfunction of NMDARs,
which results in a consequent hyper- or hypoglutamatergic state,
has been proposed to underlie some aspects of schizophrenia’s
pathophysiology (52). This glutamate hypothesis of schizophre-
nia is based on the observation that healthy subjects who received
NMDAR antagonists showed clinical features of schizophrenia,
including positive, negative, or cognitive symptoms (44, 52). Since
NMDARs are critically involved in the neuroplastic after-effects
that follow anodal and cathodal tDCS (17, 18), one could hypoth-
esize that the observed effects of impaired cortical plasticity are
possibly in line with the theory of dysfunctional NMDAR-activity
in schizophrenia. From a physiological perspective, one could fur-
ther hypothesize that a dysregulation in calcium homeostasis is
responsible for the bidirectional effects on of cortical plasticity
following tDCS in our study. It has been suggested that differ-
ent calcium levels determine the development of three different
forms of plasticity: LTD, LTP, and one zone with no plasticity
development (“no man’s land”) (53, 54). Based on this model and
that described in our previous publications (31, 55), one could
speculate that either a hyperglutamatergic state with an exces-
sive calcium influx or a reduction in NMDAR-activity resulting
in receptor hypofunction, may account for the observed plasticity
deficit. Finally, it may not be that impairments in the presynaptic
glutamate neurotransmission alone explain plasticity deficits in
patients with schizophrenia, but rather that deficits in postsynap-
tic activity of NMDAR (e.g., cell-receptor interaction) may also
play a role (56, 57). Although a possible molecular theory for the
observed plasticity deficits, this explanation remains speculative as
NMDA transmission has not been addressed directly in this study.
One remarkable finding of the presented study is that both
stimulation protocols failed to induce plasticity in patients with
schizophrenia. The complex interplay between plasticity and con-
nectivity is at the core of the popular theory published by Stephan
et al. (36). In their theory, impairments of NMDAR-activity lead
to reduced synaptic plasticity, with consequent disturbances in
micro- and macro-connectivity in the developing brain influenc-
ing all neurotransmitter systems and leading to aberrant discharge
in neural systems (36, 58). This dysconnectivity hypothesis com-
bines available evidence from structural and functional discon-
nection studies of schizophrenia. For example, a reduction in
white matter in the frontal and temporal lobes has been shown
consistently in MRI studies (59). These observations are sup-
ported by neuropathological studies in patients with schizophrenia
that indicate a loss of myelin-producing oligodendrocytes (60)
or a reduced density of dendritic spines (61) in the frontal lobe,
both of which are findings that can be closely associated with
impaired neural connectivity. Furthermore, as recently reviewed,
a functional hyperconnectivity involving different cortical and
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subcortical pathways has been linked to auditory and verbal hal-
lucinations in schizophrenia (62). Therefore, both hypo- and
hyperconnectivity have been postulated as explanations for the
pathophysiology and symptomatology underlying schizophrenia.
Our setup does only allow the indirect measurement of M1–
M1 connectivity (23) and both, impaired M1 plasticity as well as
a disrupted M1–M1 connectivity can explain the observed results.
Furthermore, it is very likely that the excitability changes in both
motor cortices interact following both stimulation setups and that
the direction of the changes are subject to considerable variability
dependent on many, as yet unidentified, factors (63). Therefore,
the final interpretation of our preliminary results has to remain
speculative. Further studies with a special attention on intra- and
intercortical M1 physiology are needed to further clarify the associ-
ation of cortical connectivity and plasticity following non-invasive
brain stimulation in schizophrenia. Due to the small sample size,
we were not able to show differences in cortical excitability (RMT,
SICI, CSP) between groups, but the numeric differences indicate
an inhibitory deficit in patients with schizophrenia, as has been
reported previously (44). Reduced inhibitory function has been
shown to affect cortical plasticity following cathodal and anodal
tDCS (29, 31), and it could be speculated that a related mecha-
nism may explain the presented results. To sum up, our findings
offer a new view on NMDAR-dependent cortical plasticity and
highlight the difficulty associated with inducing plasticity in the
schizophrenic brain with a single session of non-invasive brain
stimulation.
LIMITATIONS
For a comprehensive discussion of our observations, some impor-
tant limitations have to be taken into account. First, the impact
of antipsychotic medication on cortical plasticity following tDCS
must be highlighted as the most important possible confounding
factor. This has been discussed elsewhere (31), but in brief, the
reader should be aware that, in pharmacological studies mod-
ulating the dopaminergic system in healthy subjects, a single-
administration of dopamine agonists/antagonists indicate that
dopaminergic modulation has a strong impact on the after-effects
of tDCS (64–67). All our patients received second-generation
antipsychotics which influence the dopaminergic system. How-
ever, one should note that the cited studies used a single drug-
administration in healthy subjects and it is clear that the underly-
ing mechanisms in patients with schizophrenia receiving a long-
term treatment are different. Nonetheless, further studies inves-
tigating M1 excitability following non-invasive brain stimulation
have shown a plasticity deficit in both medicated and unmedicated
patients with schizophrenia (33, 34). The second limitation relates
to the proof-of-principle design of this study. Though being within
the range of other studies in the field, our sample size is rather
small, leading to some numeric differences between groups that do
not reach significance (see Results; Table 3). Therefore, the results
need to be confirmed in larger studies with better statistical power.
Next, due to feasibility reasons, we focused principally on cathodal
tDCS applied to the dominant hemisphere. Further studies need
to investigate unilateral and bilateral anodal tDCS applied to left
M1. The reason for our cathodal-setup was that schizophrenia is
a disorder of impaired inhibitory function and that our foregoing
studies have shown stable results using the unilateral setup (44).
Furthermore, we decided to use different stimulation durations
for unilateral and bilateral tDCS to allow comparability to other
tDCS studies in schizophrenia (9 min unilateral cathodal tDCS)
and to be within the time frame of long-lasting after effects of
anodal tDCS (13 min of anodal tDCS). As both stimulation times
are within the known optimal time frames for unilateral tDCS (14,
16), a confounding effect is not expected. However, a systematic
evaluation of these parameters is needed and should be addressed
in future studies. Finally, our bilateral setup presented here has
not been previously evaluated using a sham condition in healthy
subjects. Therefore, the lacking sham condition in our study needs
to be considered as a limiting factor.
CONCLUSION
This is the first study comparing the efficacy of unilateral and
bilateral tDCS in patients with schizophrenia. In line with previ-
ous studies, it was not possible to induce cortical plasticity using
the unilateral setup and the same was true for the bilateral setup.
These results indicate complex deficits in plasticity and connectiv-
ity in patients with schizophrenia. It may be speculated that, due
to intrinsic inhibitory dysfunction within the motor cortices, plas-
ticity processes are impaired, leading to consecutive alterations in
micro- and macro-connectivity. With regard to the possible clin-
ical application of bilateral tDCS in schizophrenia, these results
need to be taken into consideration. Assuming related deficits in
brain areas other than M1, one could hypothesize that the effi-
cacy of tDCS stimulation applied to the frontal lobe (e.g., negative
symptoms, cognitive symptoms) or to the temporal lobe (halluci-
nations) might be reduced. It is tempting to try placing the anode
on the DLPFC to enhance activity and the cathode on the tem-
poral lobe to reduce activity, with a possible consequent network
effect that improves positive and negative symptoms. Our results
urge us to remain cautious and to pay more attention to the phys-
iological underpinnings of tDCS in schizophrenia. However, the
first clinical proof-of-principle trials and case reports using both
unilateral (5, 9) and bilateral (4, 7) tDCS were promising, and it
is likely that repeated tDCS will affect the schizophrenic brain in
a different way to a single application. Further studies are needed
to clarify the clinical significance of tDCS in schizophrenia and to
identify likely responding and non-responding patients. In sum-
mary, our results indicate that prominent LTP- and LTD-plasticity
deficits can be observed in patients with schizophrenia irrespective
of the stimulation technique applied to elucidate them.
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